Trials / Sponsors / Hefei TG ImmunoPharma Co., Ltd.
Hefei TG ImmunoPharma Co., Ltd.
Academic / Other · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Me CRC (Colorectal Cancer), Melanoma (Skin Cancer), HCC - Hepatocellular Carcinoma | Phase 1 | 2025-06-12 |
| Recruiting | A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors Advanced or Metastatic Solid Tumors | Phase 1 | 2024-01-03 |
| Recruiting | A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid T Ovarian Cancer, Melanoma, Triple Negative Breast Cancer | Phase 1 | 2023-04-13 |